Literature DB >> 29045681

International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.

Joannie Lortet-Tieulent1, Jacques Ferlay2, Freddie Bray2, Ahmedin Jemal1.   

Abstract

Background: Cancers of the corpus uteri-primarily of the endometrium-rank as the sixth most common neoplasm in women worldwide. Analyses of the global patterns and trends of uterine cancer rates are needed in view of the ongoing obesity epidemic, a major risk factor for the disease.
Methods: Data on endometrial cancer (ICD-10 C54) incidence from population-based cancer registries in 43 populations, published in CI5plus or by registries, were extracted for 1978 to 2013. Age-standardized incidence rates were computed for all ages and for pre- (25-49 years) and postmenopausal ages (50 years and older). Temporal trends were assessed with Joinpoint analysis, and the effects of birth cohort and year of diagnosis on the overall trends were examined using age-period-cohort modeling.
Results: In 2006 to 2007, rates varied 10-fold across countries. The highest rates were in North America, Eastern and Northern Europe (19 cases per 100 000 among whites in the United States, 95% confidence interval [CI] = 18 to 20, and in Slovakia, 95% CI = 18 to 21), and the lowest rates were in middle-income countries (South Africa 1, 95% CI = 0 to 3, and India 3, 95% CI = 3 to 4). Rates during the most recent 10 data years increased in 26 of the 43 populations considered in this study, with South Africa and several countries in Asia showing the largest increase. The risk of endometrial cancer increased both in consecutive generations and over time in 11 of 23 populations, with the increases more pronounced in Japan, the Philippines, Belarus, Singapore, Costa Rica, and New Zealand. Conclusions: Endometrial cancer incidence rates increased over time and in successive generations in several countries, especially in those countries with rapid socioeconomic transitions.

Entities:  

Mesh:

Year:  2018        PMID: 29045681     DOI: 10.1093/jnci/djx214

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  152 in total

1.  Beyond Obesity: The Rising Incidence and Mortality Rates of Uterine Corpus Cancer.

Authors:  Megan A Mullins; Michele L Cote
Journal:  J Clin Oncol       Date:  2019-06-20       Impact factor: 44.544

Review 2.  Development of Ovulatory Menstrual Cycles in Adolescent Girls.

Authors:  Lauren J Carlson; Natalie D Shaw
Journal:  J Pediatr Adolesc Gynecol       Date:  2019-02-14       Impact factor: 1.814

3.  SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.

Authors:  Xiaofeng Jin; Jian Wang; Qian Li; Hui Zhuang; Jianye Yang; Zihan Lin; Ting Lin; Zeheng Lv; Liliang Shen; Chunhong Yan; Jingfei Zheng; Jie Zhu; Zhaohui Gong; Chenji Wang; Kun Gao
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

4.  Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.

Authors:  Kumaravel Mohankumar; Xi Li; Subhashree Sridharan; Keshav Karki; Stephen Safe
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482

5.  Endometrial cancer outcomes among non-Hispanic US born and Caribbean born black women.

Authors:  Matthew Schlumbrecht; Marilyn Huang; Judith Hurley; Sophia George
Journal:  Int J Gynecol Cancer       Date:  2019-05-03       Impact factor: 3.437

6.  Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.

Authors:  Tetsuya Kokabu; Taisuke Mori; Hiroshi Matsushima; Kaori Yoriki; Hisashi Kataoka; Yosuke Tarumi; Jo Kitawaki
Journal:  Cell Oncol (Dordr)       Date:  2019-01-31       Impact factor: 6.730

Review 7.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16

8.  Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.

Authors:  Megan A Clarke; Beverly J Long; Arena Del Mar Morillo; Marc Arbyn; Jamie N Bakkum-Gamez; Nicolas Wentzensen
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

9.  Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.

Authors:  Mara Kaspers; Elyse Llamocca; Allison Quick; Jhalak Dholakia; Ritu Salani; Ashley S Felix
Journal:  Am J Obstet Gynecol       Date:  2020-03-03       Impact factor: 8.661

Review 10.  Clinical actionability of molecular targets in endometrial cancer.

Authors:  Mary Ellen Urick; Daphne W Bell
Journal:  Nat Rev Cancer       Date:  2019-08-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.